Osprey Medical

Osprey Medical has developed and commercialized a system that reduces the volume of contrast dye injected into patients during catheterization procedures, thereby lowering the risk of contrast-induced acute kidney injury without compromising imaging quality. The company holds 50 patents related to medical equipment and cardiac procedures.\n\nNo recent clinical trial results are detailed in public sources, but their product appears to be marketed and used by healthcare providers.\n\nThe company's focus remains on improving patient safety in interventional cardiology through innovative device solutions.\n\nPipeline breadth and details are not explicitly listed beyond their core product.